Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands
| Autor: | Don Klinkenberg, Marit M A de Lange, Adam Meijer, Lenny Stoeldraijer, Wim van der Hoek, Anne C. Teirlinck, Liselotte van Asten, Carel Harmsen, Susan van den Hof, Jan van de Kassteele, Arianne B van Gageldonk-Lafeber |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Epidemiology
coronavirus lcsh:Medicine Disease mortality rate medicine.disease_cause excess deaths 0302 clinical medicine Case fatality rate Medicine 030212 general & internal medicine Coronavirus Netherlands biology seasonality Mortality rate Orthomyxoviridae Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2 the Netherlands Infectious Diseases coronavirus disease surveillance Seasons influenza influenza viruses severe acute respiratory syndrome coronavirus 2 Microbiology (medical) trends medicine.medical_specialty Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 030231 tropical medicine epidemics lcsh:Infectious and parasitic diseases 03 medical and health sciences respiratory infections Influenza Human infection-fatality rate Humans viruses lcsh:RC109-216 Disease burden business.industry SARS-CoV-2 Research the Netherlands lcsh:R COVID-19 Seroepidemiologic Studies biology.organism_classification mortality zoonoses Emergency medicine time series business |
| Zdroj: | Emerging Infectious Diseases, Vol 27, Iss 2, Pp 411-420 (2021) Emerging Infectious Diseases |
| ISSN: | 1080-6059 1080-6040 |
| Popis: | Since the 2009 influenza pandemic, the Netherlands has used a weekly death monitoring system to estimate deaths in excess of expectations. We present estimates of excess deaths during the ongoing coronavirus disease (COVID-19) epidemic and 10 previous influenza epidemics. Excess deaths per influenza epidemic averaged 4,000. The estimated 9,554 excess deaths (41% in excess) during the COVID-19 epidemic weeks 12-19 of 2020 appeared comparable to the 9,373 excess deaths (18%) during the severe influenza epidemic of 2017-18. However, these deaths occurred in a shorter time, had a higher peak, and were mitigated by nonpharmaceutical control measures. Excess deaths were 1.8-fold higher than reported laboratory-confirmed COVID-19 deaths (5,449). Based on excess deaths and preliminary results from seroepidemiologic studies, we estimated the infection-fatality rate to be 1%. Monitoring of excess deaths is crucial for timely estimates of disease burden for influenza and COVID-19. Our data complement laboratory-confirmed COVID-19 death reports and enable comparisons between epidemics. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|